Aeva Technologies, Inc.
AEVA Nasdaq Motor Vehicle Parts & Accessories Financials FY2019βFY2025
What Aeva Technologies, Inc. does
No business description yet.
- Legal name
- Aeva Technologies, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 20, 2026
- Accession Β· CIK
- 0001193125-26-116518
0001789029
Revenue and margins
Aeva Technologies, Inc. had $18.1M of revenue in fiscal 2025, up 99.4% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$120M in fiscal 2025, β662.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Aeva Technologies, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 6.9%.
Balance sheet
Cash, debt and the ratios that show how comfortably Aeva Technologies, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $445M | $324M | $221M | $112M | $122M |
| Current ratio | 32.1x | 15.4x | 12.5x | 3.1x | 4.3x |
| Quick ratio | 31.9x | 15.2x | 12.3x | 3.1x | 4.1x |
| Total assets | $479M | $357M | $257M | $147M | $180M |
| Total liabilities | $22.8M | $26.7M | $28.9M | $48.1M | $166M |
| Shareholders' equity | $456M | $330M | $228M | $99.4M | $13.2M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 8 | 3 / 8 | 2 / 8 | 2 / 8 | 3 / 8 | 5 / 8 |
| Accruals ratio | β3,002.8% | β26.5% | β7.7% | β8.9% | β9.9% | β22.4% | β18.6% |
| Altman Z'' | β644.26 | β1.38 | 24.52 | 13.04 | 3.98 | β14.83 | β14.13 |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $1.4M | $4.8M | $9.3M | $4.2M | $4.3M | $9.1M | $18.1M |
| Gross profit | $0.6M | $2.1M | $3.4M | β$4.3M | β$5.9M | β$3.8M | β$0.7M |
| Research and development | $15.4M | $20.5M | $74.8M | $110M | $103M | $103M | $85.4M |
| Operating income | β$20.1M | β$25.7M | β$104M | β$152M | β$148M | β$158M | β$128M |
| Pretax income | β$19.6M | β$25.6M | β$102M | β$147M | β$149M | β$152M | β$145M |
| Income tax | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.2M | $0.3M |
| Net income | β$19.6M | β$25.6M | β$102M | β$147M | β$149M | β$152M | β$145M |
| Net income to common | β$19.6M | β$25.6M | β$102M | β$147M | β$149M | β$152M | β$145M |
| Diluted EPS | β$0.17 | β$0.18 | β$0.51 | β$3.39 | β$3.29 | β$2.85 | β$2.55 |
| Diluted shares | 0.11B | 0.14B | 0.20B | 0.04B | 0.05B | 0.05B | 0.06B |
| Cash flow | |||||||
| Cash from operations | β$16.4M | β$21.2M | β$82.1M | β$110M | β$119M | β$107M | β$115M |
| Capital expenditure | $0.4M | $0.9M | $3.9M | $7.4M | $6.1M | $5.1M | $4.6M |
| Free cash flow | β$16.8M | β$22.1M | β$86.0M | β$117M | β$125M | β$112M | β$120M |
| Depreciation and amortization | $0.6M | $0.8M | $1.1M | $3.3M | $4.6M | $5.5M | $5.4M |
| Stock-based compensation | $2.2M | $3.8M | $22.2M | $24.2M | $23.7M | $23.7M | $21.8M |
| Balance sheet | |||||||
| Cash and short-term investments | $46.6M | $24.6M | $445M | $324M | $221M | $112M | $122M |
| Current assets | $0.0M | $31.0M | $458M | $335M | $229M | $123M | $154M |
| Current liabilities | $0.1M | $5.7M | $14.3M | $21.8M | $18.4M | $39.2M | $35.9M |
| Inventory | β | $1.2M | $2.1M | $3.0M | $2.4M | $2.3M | $5.8M |
| Property and equipment, net | β | $1.6M | $5.1M | $9.7M | $12.1M | $10.3M | $12.8M |
| Intangible assets | β | $0.0M | $4.4M | $3.5M | $2.6M | $1.7M | $0.8M |
| Total assets | $0.1M | $32.6M | $479M | $357M | $257M | $147M | $180M |
| Total liabilities | $0.1M | $5.7M | $22.8M | $26.7M | $28.9M | $48.1M | $166M |
| Shareholders' equity | $48.6M | $26.9M | $456M | $330M | $228M | $99.4M | $13.2M |
| Margins | |||||||
| Gross margin | 41.1% | 43.4% | 37.0% | β101.5% | β136.5% | β41.8% | β3.7% |
| Operating margin | β1,451.8% | β531.5% | β1,124.5% | β3,624.9% | β3,427.4% | β1,747.1% | β705.8% |
| EBITDA margin | β1,406.0% | β515.0% | β1,112.1% | β3,547.0% | β3,320.2% | β1,686.6% | β676.0% |
| Net margin | β1,415.8% | β528.0% | β1,099.6% | β3,514.0% | β3,463.2% | β1,679.7% | β804.4% |
| FCF margin | β1,214.2% | β456.0% | β927.7% | β2,799.4% | β2,897.3% | β1,235.7% | β662.0% |
| Returns | |||||||
| Return on capital employed | β80,051.8% | β95.5% | β22.4% | β45.4% | β61.8% | β146.2% | β88.7% |
| Return on equity | β40.3% | β67.7% | β42.2% | β37.5% | β53.5% | β92.9% | β258.4% |
| Return on assets | β18,329.3% | β156.2% | β39.8% | β35.2% | β48.6% | β75.2% | β88.9% |
| Return on tangible equity | β40.3% | β95.0% | β22.5% | β45.1% | β66.1% | β156.0% | β1,173.8% |
| Growth | |||||||
| Revenue growth | β | 249.9% | 91.3% | β54.8% | 2.9% | 110.2% | 99.4% |
| Share count change | β | 23.3% | 41.7% | β78.4% | 4.5% | 17.5% | 6.9% |
| Financial health | |||||||
| Current ratio | 0.0x | 5.5x | 32.1x | 15.4x | 12.5x | 3.1x | 4.3x |
| Quick ratio | 0.0x | 5.2x | 31.9x | 15.2x | 12.3x | 3.1x | 4.1x |
| Capital allocation | |||||||
| Capex / revenue | 30.4% | 17.7% | 41.6% | 177.5% | 141.6% | 56.3% | 25.5% |
| Stock comp / revenue | 155.6% | 78.6% | 240.0% | 578.4% | 549.0% | 261.5% | 120.8% |
| Quality scores | |||||||
| Piotroski F-score | β | 4.0 | 3.0 | 2.0 | 2.0 | 3.0 | 5.0 |
| Altman Z'' | β644.3 | β1.4 | 24.5 | 13.0 | 4.0 | β14.8 | β14.1 |
| Accruals ratio | β3,002.8% | β26.5% | β7.7% | β8.9% | β9.9% | β22.4% | β18.6% |
Source: SEC EDGAR XBRL filings (CIK 0001789029). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.